2025 Scrip Asia 100
Latest Updates And Considerations In Asia Pacific
Emerging Modalities
Tailwinds in cell and gene therapy development across Asia have necessitated new strategies for commercialization of these innovative treatments in various global markets.
As India Scales CAR-T Efforts, Can It Innovate Commercial Models?
As India seeks to build on early gains in CAR-T cell therapy, experts call for ecosystem reform and also the need to demonstrate value to payer models of large economies to potentially back international reimbursements.
